Variant report
Variant | esv1842590 |
---|---|
Chromosome Location | chr1:104640211-104672052 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:104659954..104662571-chr1:104673545..104675551,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AMY1C-2 | chr1:104668178-104668541 | NONHSAT004905 |
2 | lnc-AMY1C-2 | chr1:104668179-104668541 | XLOC_000326 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551626724 | chr1:104646800-104646801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571906335 | chr1:104646869-104646870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531117685 | chr1:104646880-104646881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1411471 | chr1:104646902-104646903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs537168665 | chr1:104646910-104646911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555143738 | chr1:104646944-104646945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1411472 | chr1:104646982-104646983 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs1411473 | chr1:104646986-104646987 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs192097686 | chr1:104646991-104646992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577965779 | chr1:104647011-104647012 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111994920 | chr1:104647013-104647014 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs57830228 | chr1:104647028-104647029 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs61788842 | chr1:104647083-104647084 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561553354 | chr1:104647096-104647097 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575404819 | chr1:104647116-104647117 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543109978 | chr1:104647157-104647158 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74459830 | chr1:104647179-104647180 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528574748 | chr1:104647192-104647193 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188379624 | chr1:104647213-104647214 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565254444 | chr1:104647307-104647308 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372909480 | chr1:104647328-104647329 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs533303319 | chr1:104647366-104647367 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192851713 | chr1:104647406-104647407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78330572 | chr1:104647409-104647410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184226950 | chr1:104647426-104647427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549072242 | chr1:104647428-104647429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567291155 | chr1:104647557-104647558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534714192 | chr1:104647591-104647592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78689280 | chr1:104648207-104648208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567466261 | chr1:104648219-104648220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75423318 | chr1:104648220-104648221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147530939 | chr1:104648247-104648248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528190305 | chr1:104648250-104648251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76871938 | chr1:104648256-104648257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370219899 | chr1:104648265-104648266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78027250 | chr1:104648276-104648277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538205873 | chr1:104648312-104648313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148517378 | chr1:104648369-104648370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569494622 | chr1:104648395-104648396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536927467 | chr1:104648397-104648398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372478170 | chr1:104648405-104648406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115682711 | chr1:104648452-104648453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs79226699 | chr1:104648483-104648484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554349655 | chr1:104648509-104648510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs151023877 | chr1:104648541-104648542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76300243 | chr1:104648563-104648564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115938570 | chr1:104648583-104648584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183967452 | chr1:104648587-104648588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530742909 | chr1:104648600-104648601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537908482 | chr1:104661400-104661401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104646800-104647000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr1:104647000-104647400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr1:104647400-104647600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr1:104648200-104648600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr1:104661400-104661800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr1:104663800-104664200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr1:104663800-104664400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr1:104664400-104668000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:104667400-104667800 | Enhancers | Fetal Heart | heart |
10 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells | blood |
11 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr1:104667800-104669200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr1:104668000-104668400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr1:104668000-104668400 | Enhancers | Placenta Amnion | Placenta Amnion |
15 | chr1:104668000-104669400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
16 | chr1:104668200-104668800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr1:104668400-104674800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr1:104668600-104669000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr1:104669400-104678400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |